Diagnostic Medical Systems (STU:DMS1) Accounts Payable: €14.03 Mil (As of Dec. 2025)


STU:DMS1 Diagnostic Medical Systems STU:DMS1
47 GF Score
Price €1.20
GF Value €1.14
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Diagnostic Medical Systems Accounts Payable?

Diagnostic Medical Systems STU:DMS1 +4.37% 47 Accounts Payable is €14.03 Mil as of Dec. 2025. GuruFocus rates STU:DMS1 with a GF Score™ of 47/100 and a GF Value™ of €1.14 (Fairly Valued). The stock has 4 warning signs investors should review.

Diagnostic Medical Systems's Accounts Payable for the quarter that ended in Dec. 2025 was €14.03 Mil.

Diagnostic Medical Systems's quarterly Accounts Payable declined from Jun. 2024 (€11.68 Mil) to Dec. 2024 (€10.85 Mil) but then increased from Dec. 2024 (€10.85 Mil) to Dec. 2025 (€14.03 Mil).

Diagnostic Medical Systems's annual Accounts Payable increased from Dec. 2023 (€10.41 Mil) to Dec. 2024 (€10.85 Mil) and increased from Dec. 2024 (€10.85 Mil) to Dec. 2025 (€14.03 Mil).

Diagnostic Medical Systems Accounts Payable Related Terms

Diagnostic Medical Systems Accounts Payable Historical Data

* Premium members only.

The historical data trend for Diagnostic Medical Systems's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diagnostic Medical Systems Accounts Payable Chart

Diagnostic Medical Systems Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.71 11.04 10.41 10.85 14.03

Diagnostic Medical Systems Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Dec25
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.93 10.41 11.68 10.85 14.03
STU:DMS1
47GF Score
Diagnostic Medical Systems STU:DMS1
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Diagnostic Medical Systems Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of €14.03 Mil mean?
Diagnostic Medical Systems (STU:DMS1) has a Accounts Payable of €14.03 Mil as of Dec. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Diagnostic Medical Systems and its competitors.
Is Diagnostic Medical Systems' Accounts Payable too high?
Diagnostic Medical Systems' current Accounts Payable is €14.03 Mil. Overall, Diagnostic Medical Systems has a GF Score™ of 47/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Diagnostic Medical Systems' Accounts Payable compare to ABT and SYK?
Diagnostic Medical Systems' Accounts Payable of €14.03 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Devices & Instruments company?
A good Accounts Payable depends on the Medical Devices & Instruments industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Diagnostic Medical Systems and its competitors. Diagnostic Medical Systems's current Accounts Payable is €14.03 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diagnostic Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, Diagnostic Medical Systems (STU:DMS1) is currently considered Fairly Valued. The stock's GF Value™ is €1.14, compared to a current price of €1.20 — trading 4.8% above its estimated fair value. The current Accounts Payable is €14.03 Mil. Diagnostic Medical Systems' overall GF Score™ is 47/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Diagnostic Medical Systems (STU:DMS1), the current Accounts Payable is €14.03 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Diagnostic Medical Systems (STU:DMS1) Overvalued in 2026?

Based on GuruFocus' analysis, Diagnostic Medical Systems stock appears to be overvalued. The current stock price of €1.20 is trading 4.8% above its estimated GF Value™ of €1.14. GuruFocus considers Diagnostic Medical Systems to be Fairly Valued.

Key valuation signals for STU:DMS1:

  • Accounts Payable: €14.03 Mil
  • GF Value™: €1.14 vs. price of €1.20 (4.8% above fair value)
  • GF Score™: 47/100 with 4 warning signs

No single metric tells the full story. See the STU:DMS1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Diagnostic Medical Systems Business Description

Other Exchanges 0RIA:UKALDMS:France
Address 9 Avenue du Canal Philippe, Gallargues le Montueux, FRA, FR-30660
Diagnostic Medical Systems is France's company engaged in the development, design, and production of imaging systems for digital and conventional radiology and osteodensitometry. The group's activity is organized around two sectors: Radiology equipment and osteodensitometers sales: mobile radiology units, floating table tops, operating room mobile amplifiers, ultrasound osteodensitometers (designed to chart the bone micro-architecture) and X ray osteodensitometers (designed to measure bone density), etc. The group also proposes devices distribution and maintenance activities; and the Development of biotechnology solutions: in the fields of arthrosis treatment and regenerative medicine.
47GF Score

Get the complete analysis for STU:DMS1

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.20
Price
€1.14
GF Value